Literature DB >> 2142584

Susceptibility of laboratory rats to isolates of Borrelia burgdorferi from different geographic areas.

S W Barthold1, K D Moody, D S Beck.   

Abstract

One week old LEW/N rats were inoculated with 15 different isolates of Borrelia burgdorferi from 3 major North American (Northeast, Midwest, and Pacific) and 1 European endemic areas. At 30 days after inoculation, several tissues were cultured for B. burgdorferi and examined for histopathological changes. Sera were tested for IgM and IgG antibody to B. burgdorferi by an enzyme-linked immunosorbent assay. One or more isolates from each geographic region was recovered by culture and caused arthritis in the rats. No differences in pattern or severity of disease were apparent among pathogenic isolates. Several recovered isolates failed to infect rats, or did not cause disease. Rats that were actively infected seroconverted but uninfected rats did not. Infectivity and pathogenicity of B. burgdorferi isolates could not be correlated with molecular weights or expression of outer surface proteins based on agar gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142584     DOI: 10.4269/ajtmh.1990.42.596

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Comparison of infectivities of six tick-derived isolates of Borrelia burgdorferi for rodents and ticks.

Authors:  C A Peavey; R S Lane
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Infectious but nonpathogenic isolate of Borrelia burgdorferi.

Authors:  J F Anderson; S W Barthold; L A Magnarelli
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease.

Authors:  P M Pennington; C D Allred; C S West; R Alvarez; A G Barbour
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

6.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Experimental Borrelia burgdorferi infection of outbred mice.

Authors:  T Masuzawa; Y Beppu; H Kawabata; Y Yanagihara; Y Iwamoto; T Shimizu; R C Johnson
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

8.  Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease.

Authors:  R J Shoberg; M Jonsson; A Sadziene; S Bergström; D D Thomas
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 9.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.